Fuji Pharma Co., Ltd. (TYO:4554)

Fuji Pharma Revenue

Fuji Pharma had revenue of 13.82B JPY in the quarter ending March 31, 2026, with 24.55% growth. This brings the company's revenue in the last twelve months to 57.30B, up 17.31% year-over-year. In the fiscal year ending September 30, 2025, Fuji Pharma had annual revenue of 51.68B with 12.01% growth.

• Revenue (ttm): 57.30B
• Revenue Growth: +17.31%
• P/S Ratio: 1.05
• Revenue / Employee: 32.56M
• Employees: 1,760
• Market Cap: 60.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	51.68B	5.54B	12.01%
Sep 30, 2024	46.14B	5.25B	12.84%
Sep 30, 2023	40.89B	5.46B	15.42%
Sep 30, 2022	35.43B	1.44B	4.22%
Sep 30, 2021	33.99B	197.00M	0.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error